A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)

Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe

(2018) David B. Huang et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

(2017) J Pullman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

New therapeutic options for skin and soft tissue infections

(2016) Matteo Bassetti et al.   CURRENT OPINION IN INFECTIOUS DISEASES

A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia

(2016) Yuki Hanai et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Mechanisms of drug resistance: daptomycin resistance

(2015) Truc T. Tran et al.   Annals of the New York Academy of Sciences

Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

(2014) Dennis L. Stevens et al.   CLINICAL INFECTIOUS DISEASES

Multistate Point-Prevalence Survey of Health Care–Associated Infections

(2014) Shelley S. Magill et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daptomycin non-susceptible Staphylococcus aureus at a US medical centre

(2013) A. Velazquez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus

(2010) Esteban Nannini et al.   CURRENT OPINION IN PHARMACOLOGY

Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit

(2010) Miguel Sánchez García   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

In Vitro Bactericidal Activity of Iclaprim in Human Plasma

(2009) H. Laue et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates

(2009) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure Infections

(2007) John Edelsberg et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY